1. United States
2. Ga.
3. Letter

The United States relies heavily on foreign supply chains for the production of many essential pharmaceuticals and their active ingredients. Imposing significant tariffs on imported drugs could severely disrupt this existing supply and lead to critical shortages before domestic manufacturing can be ramped up. This would put American lives at risk and cause prices to skyrocket for consumers desperately in need of affordable medications. While bringing more pharmaceutical manufacturing back to the US is a laudable long-term goal, any such initiative must be implemented gradually and with careful planning to avoid catastrophic consequences for public health and access to vital medicines. We cannot afford to jeopardize the existing drug supply without viable domestic alternatives firmly in place first. I urge you to consider a more measured approach that safeguards this crucial aspect of our healthcare system during any transition period.